| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 10/03/2001 | CN1315851A Oral care compositions |
| 10/02/2001 | US6297375 4-phenyl-pyridine derivatives |
| 10/02/2001 | US6297243 Methods of treating hot flashes, estrogen deficiencies and deferring menopause by the administration of a luteinizing hormone antagonist |
| 10/02/2001 | US6297223 Administering 5-substituted- or 5,6-dihydro-5-substituted-uracil derivative or a prodrug thereof; in conjunction with 5-fluorouracil or pro-drug thereof. |
| 10/02/2001 | US6296834 Oral care composition |
| 09/27/2001 | WO2001070741A1 5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors |
| 09/27/2001 | WO2001070736A1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants |
| 09/27/2001 | WO2001070194A1 Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent |
| 09/27/2001 | WO2001070188A1 LOW pH HIGH FATTY ACID VANISHING CREAM |
| 09/27/2001 | WO2001070187A1 LOW pH HIGH FATTY ACID VANISHING CREAM |
| 09/27/2001 | WO2001019320A3 Phospholipid prodrugs of anti-proliferative drugs |
| 09/27/2001 | US20010025106 Antiallergens, bronchodilator |
| 09/27/2001 | US20010025051 Administering to a breast cancer patient an effective amount of hydroxy containing bicyclic aromatic or heteroaromatic derivatives |
| 09/27/2001 | US20010024824 Stem cells and their use in transplantation |
| 09/27/2001 | US20010024664 Alzheimer's diseases; central nervous system disorders; antiinflammatory agent; solvent extraction from plants |
| 09/27/2001 | CA2401368A1 5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors |
| 09/26/2001 | EP1135400A1 Hygromycin a derivatives as antibacterial agents |
| 09/26/2001 | EP1135391A1 Novel triazolo(4,5-d)pyrimidine compounds |
| 09/26/2001 | EP1135381A1 Eletriptan hydrobromide monohydrate |
| 09/26/2001 | EP1135367A1 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same |
| 09/26/2001 | EP1135159A2 Peptide-based vaccine for influenza |
| 09/26/2001 | EP1135108A1 Method for producing agglomerates comprising a core-shell structure |
| 09/26/2001 | EP1135102A1 Cosmetic skin care compositions containing 4-chromanone |
| 09/26/2001 | CN1314888A Crystalline forms of osanetant |
| 09/26/2001 | CN1314887A Ester of (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol and their use as prodrugs of the 5HT2A receptor antagonist MDL 110,907 |
| 09/26/2001 | CN1071791C DNA molecule for coding BSSL/CEL |
| 09/20/2001 | WO2001068044A1 Oral composition comprising 2'-hydroxypropiophenone |
| 09/20/2001 | WO2001013953A3 Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist |
| 09/20/2001 | WO2001013944A3 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 09/20/2001 | US20010022975 Topical gel; containing vasodilator |
| 09/19/2001 | EP1133477A1 Substituted benzimidazoles and their use as parp inhibitors |
| 09/19/2001 | EP1133281A1 Dispersible phospholipid stabilized microparticles |
| 09/19/2001 | EP1133277A1 Pharmaceutical aerosol composition containing hfa 227 and hfa 134a |
| 09/19/2001 | CN1313862A Novel 17-halogenated 19-Nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 09/19/2001 | CN1313861A 2-(purin-9-YL)-tetrahydrofuran-3,4-diolderivatives |
| 09/19/2001 | CN1071118C Pyrazolopyrimidone for treating impotence |
| 09/18/2001 | US6291649 Anti-bodies binding adhesin-derived antigens |
| 09/18/2001 | US6291519 Method of preventing damage to eye tissue |
| 09/18/2001 | US6291516 Contacting the cell with a composition including at least one cyclic amp agonist. |
| 09/18/2001 | US6291458 Morpholinobenzamide salts |
| 09/18/2001 | US6290969 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 09/18/2001 | CA2168364C Stabilized pharmaceutical composition containing bupropion |
| 09/13/2001 | WO2001066093A2 Sustained release ranolazine formulations |
| 09/13/2001 | WO2001030759A3 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 09/13/2001 | WO2001028992A3 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 09/13/2001 | WO2001026666A3 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba |
| 09/13/2001 | WO1997013492A3 Strengthening agent |
| 09/13/2001 | US20010021791 Cyclopropyl phenyl ketone compound |
| 09/13/2001 | US20010021722 Pharmaceutical compositions comprising monoamine oxidase b inhibitors |
| 09/13/2001 | US20010021400 Tanacetum parthenium extract and method of obtaining same |
| 09/13/2001 | US20010021371 Ultrasonic images using contrast agent |
| 09/12/2001 | EP1132090A1 Method for producing an agent for treating non-cancerous pathologies of the organism |
| 09/12/2001 | EP1132079A1 Washing composition for keratinic materials comprising a low-ethoxylated sorbitan ester |
| 09/12/2001 | EP1131301A1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 09/12/2001 | EP1131086A2 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto |
| 09/12/2001 | EP1131085A2 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 09/12/2001 | EP1131075A2 Use of phosphonoformic acid derivatives for treating infections |
| 09/12/2001 | EP1131059A1 Dry powder for inhalation |
| 09/12/2001 | EP1131051A1 Pressurised metered dose inhalers (mdi) |
| 09/12/2001 | EP0817775B1 Quinazoline derivatives |
| 09/12/2001 | CN1312812A Muscarinic agonists and antagonists |
| 09/12/2001 | CN1312724A TNF-drvived peptides of use in treating oedema |
| 09/12/2001 | CN1312719A Pharmaceutical Composition |
| 09/12/2001 | CN1070849C Enzyme inhibitors |
| 09/12/2001 | CN1070700C Process for preparation of medicine containing flupirtine and use to combat muscular tension thereof |
| 09/11/2001 | US6288241 Crystalline polymorphic form of 1-methyl-5-p-toluoylpyrrple-2-acetamidoacetic acid guaiacyl ester (MED 15) |
| 09/11/2001 | US6288104 Administering seretonin uptake inhibitors to treat depression, psychological and psychiatric disorders with an anxiety component, alcohol and drug dependence, bulimia nervosa and obsessive-compulsive disorders |
| 09/11/2001 | US6288056 Intermittent claudication therapeutic drugs comprising pyrroloazepines |
| 09/11/2001 | US6288047 Lipid-based immune modulator composition |
| 09/11/2001 | US6288044 O-sulfated bacterial polysaccharides |
| 09/11/2001 | US6287553 Skin care composition |
| 09/11/2001 | US6287541 Oral care compositions |
| 09/11/2001 | US6287540 Therapeutic dry powder |
| 09/07/2001 | WO2001064672A1 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs |
| 09/07/2001 | WO2001064232A1 Use of avocado-soybean unsaponifiable preparations |
| 09/07/2001 | WO2001064229A1 A medicine for treating obesity and the method of producing thereof |
| 09/07/2001 | WO2001064183A1 Orally administered controlled delivery system for once daily administration of ciprofloxacin |
| 09/07/2001 | WO2001064182A2 Improvements in or relating to the delivery of oral drugs |
| 09/07/2001 | WO2001064163A2 An improved herbal composition having antiallergic properties and a process for the preparation thereof |
| 09/07/2001 | WO2000054763A3 Pharmaceutical compositions comprising polymorphic forms of dehydroepiandrosterone |
| 09/07/2001 | CA2401288A1 Improvements in or relating to the delivery of oral drugs |
| 09/07/2001 | CA2400950A1 Orally administered controlled delivery system for once daily administration of ciprofloxacin |
| 09/06/2001 | US20010020147 Delivery of oral drugs |
| 09/06/2001 | US20010020114 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 09/06/2001 | US20010020036 Synergistic mixtures |
| 09/06/2001 | US20010020022 2{3-[4-(2-t-butyl-6-trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto} pyrimidin-4-ol-fumarate |
| 09/06/2001 | US20010020016 Formulation |
| 09/05/2001 | EP1129075A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors |
| 09/05/2001 | EP1128813A1 An inhalation system |
| 09/05/2001 | EP1128803A1 Antiperspirant formulation for porous applicator |
| 09/05/2001 | EP1128799A2 Fluorinated toothpaste composition comprising calcic material abrasive particles compatible with fluorine |
| 09/05/2001 | CN1311822A Gene therapy method |
| 09/05/2001 | CN1311818A Neurotrophic factors |
| 09/05/2001 | CN1311787A Oxazolidinone derivatives, process for their prepn. and pharmaceutical compositions contg. same |
| 09/05/2001 | CN1311674A Antioxidant, antiproliferous compositions, comprising a carnitine and a cerotenoid |
| 09/05/2001 | CN1311660A Anti-germ attachment composition |
| 09/05/2001 | CN1311658A Dentifrice composition contg. encapsulated reactive ingredients |
| 09/05/2001 | CN1310999A Low dose Etikavi Prepn. and the use thereof |
| 09/04/2001 | US6284774 4-Benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonists |
| 09/04/2001 | US6284764 Antiproliferative agent |